Investors sent Structure Therapeutics' stock flying high after the company disclosed results from two studies testing ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...
Security and developer teams are scrambling to address a highly critical security flaw in frameworks tied to the popular React JavaScript library. Not only is the vulnerability, which also is in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback